论文部分内容阅读
据《中国医学论坛报》31卷10期14版报道(记者吕强)德国Kastrati进行的研究表明,预防支架内再狭窄的复发,药物洗脱支架置入优于球囊扩张术。(JAMA2005,293:165)在冠状动脉再损伤中,与裸支架和单纯球囊扩张成形术相比,药物洗脱支架明显降低了再狭窄的危险。但对于支架内再狭窄的患者,药物洗脱支架是否优于球囊扩张术还不十分清楚。该研究目的就是评价药物洗脱支架是否较单纯球囊扩张成形术治疗支架内再狭窄更有效,同时比较两种不同的药物洗脱支架(西罗莫司洗脱支架和紫杉醇洗脱支架)哪种更优越。
According to the “China Medical Tribune” Vol. 31, No. 10 (14), a study conducted by Kastrati in Germany showed that drug-eluting stent placement is superior to balloon dilatation in preventing the recurrence of in-stent restenosis. (JAMA 2005, 293: 165) In coronary re-injury, drug-eluting stents significantly reduce the risk of restenosis compared to bare-stent and balloon-only stenting. However, it remains unclear whether a drug-eluting stent is superior to balloon dilatation in patients with in-stent restenosis. The purpose of this study was to evaluate whether drug-eluting stents are more effective than balloon-assisted balloon angioplasty in the treatment of in-stent restenosis and to compare two different drug-eluting stents (sirolimus-eluting stents and paclitaxel-eluting stents) More superior species.